{"transactions":[{"id":3140972,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":1178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F21","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V CAN without consideration to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F20","text":"The shares are held by VV V CAN."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140971,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":true,"shares":1178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F19","text":"Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC CAN."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F20","text":"The shares are held by VV V CAN."}],"balance_after":1178,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140970,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":16428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F18","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V without consideration to its members."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F17","text":"The shares are held by VV V."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140969,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":true,"shares":16428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC V, VAF V and VOA."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F17","text":"The shares are held by VV V."}],"balance_after":16428,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140968,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":58889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC CAN without consideration to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F11","text":"These securities are held of record by VVC CAN. VV V CAN GP is the sole general partner of \"VV V CAN and VV V CAN is the sole general partner of VVC CAN. By virtue of such relationships, VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities. VV V CAN disclaims beneficial ownership of the shares held by VVC CAN, except to the extent of its pecuniary interests therein."}],"balance_after":109374,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140967,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":25794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VOA without consideration to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of such shares except to the extent of its pecuniary interests therein."}],"balance_after":47823,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140966,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":23275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VAF V without consideration to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial owners of such shares except to the extent of its pecuniary interest therein."}],"balance_after":43231,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140965,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-05-18","kind":"other","acquired":false,"shares":773805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC V without consideration to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are held of record by VVC V.  VV  is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VVC V disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":1437132,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140964,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":168263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a change in the form of ownership of VVC CAN by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F11","text":"These securities are held of record by VVC CAN. VV V CAN GP is the sole general partner of \"VV V CAN and VV V CAN is the sole general partner of VVC CAN. By virtue of such relationships, VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities. VV V CAN disclaims beneficial ownership of the shares held by VVC CAN, except to the extent of its pecuniary interests therein."}],"balance_after":168263,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140963,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":73617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a change in the form of ownership of VOA by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of such shares except to the extent of its pecuniary interests therein."}],"balance_after":73617,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140962,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":66506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VAF V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial owners of such shares except to the extent of its pecuniary interest therein."}],"balance_after":66506,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140961,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":2210937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents a change in the form of ownership of VVC V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are held of record by VVC V.  VV  is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VVC V disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":2210937,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3140960,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":4,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":6,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":7,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:59:15.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":2519323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant V Luxco S.a.r.l. (\"Luxco\")  to its shareholders without consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These Shares are directly held by Versant VI Luxco S.a.r.l. (\"Luxco\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Luxco is majority owned by Versant Venture Capital V, L.P.(\"VVC V\") and minority owned by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOA\"), Versant Affiliates Fund V, L.P. (\"VAF V\" and together with VVC V and VOA, the \"Versant Funds\") and Versant Venture Capital V (Canada) LP (\"VVC CAN\"). Versant Ventures V, LLC (\"VV V\") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. (\"VV V CAN GP\") is the general partner of Versant Ventures V (Canada), L.P. (\"VV V CAN\"), which is the general partner of VVC CAN."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000110465920064448/a4.xml","form_type":"4"}},{"id":3396694,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"ten_percent_owner":true}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":2,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"ten_percent_owner":true}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":3,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"ten_percent_owner":true}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":4,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"ten_percent_owner":true}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"ten_percent_owner":true}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":6,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":7,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"ten_percent_owner":true}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":8,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-10-07T19:39:20.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":512995,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the \"Versant Funds\") and Versant Venture Capital V (Canada) LP (\"Versant Canada\"). Versant Ventures V, LLC (\"Ventures V\") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":512995},"source":{"system":"sec-edgar","filing":"0001140361-19-018090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000114036119018090/form4.xml","form_type":"4"}},{"id":3396693,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"ten_percent_owner":true}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":2,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"ten_percent_owner":true}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":3,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"ten_percent_owner":true}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":4,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"ten_percent_owner":true}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"ten_percent_owner":true}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":6,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":7,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"ten_percent_owner":true}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":8,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-10-07T19:39:20.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":1993658,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the \"Versant Funds\") and Versant Venture Capital V (Canada) LP (\"Versant Canada\"). Versant Ventures V, LLC (\"Ventures V\") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1993658},"source":{"system":"sec-edgar","filing":"0001140361-19-018090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000114036119018090/form4.xml","form_type":"4"}},{"id":3396692,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"ten_percent_owner":true}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":2,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"ten_percent_owner":true}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":3,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"ten_percent_owner":true}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":4,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"ten_percent_owner":true}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"ten_percent_owner":true}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":6,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":7,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"ten_percent_owner":true}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":8,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-10-07T19:39:20.000Z","date":"2019-10-07","kind":"purchase","acquired":true,"shares":333333,"price":15,"value":4999995.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These Shares are directly held by Versant Vantage I, L.P.  Versant Vantage I GP-GP, LLC is the general partner of Versant Vantage I GP, L.P., which is the general partner of Versant Vantage I, L.P.  Each of Versant Vantage I GP-GP, LLC and Versant Vantage I GP, L.P. may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage I, L.P., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These Shares are directly held by Versant Vantage I, L.P.  Versant Vantage I GP-GP, LLC is the general partner of Versant Vantage I GP, L.P., which is the general partner of Versant Vantage I, L.P.  Each of Versant Vantage I GP-GP, LLC and Versant Vantage I GP, L.P. may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage I, L.P., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."}],"balance_after":333333,"source":{"system":"sec-edgar","filing":"0001140361-19-018090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000114036119018090/form4.xml","form_type":"4"}},{"id":3396691,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"ten_percent_owner":true}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":2,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"ten_percent_owner":true}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":3,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"ten_percent_owner":true}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":4,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"ten_percent_owner":true}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"ten_percent_owner":true}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":6,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":7,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"ten_percent_owner":true}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":8,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-10-07T19:39:20.000Z","date":"2019-10-07","kind":"exercise","acquired":true,"shares":512995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the \"Versant Funds\") and Versant Venture Capital V (Canada) LP (\"Versant Canada\"). Versant Ventures V, LLC (\"Ventures V\") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."}],"balance_after":2519323,"source":{"system":"sec-edgar","filing":"0001140361-19-018090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000114036119018090/form4.xml","form_type":"4"}},{"id":3396690,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":149073,"kind":"organization","name":"Versant V Luxco S.a r.l.","position":1,"cik":"0001786141","reported_name":"Versant V Luxco S.a r.l.","relationship":{"ten_percent_owner":true}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":2,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"ten_percent_owner":true}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":3,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"ten_percent_owner":true}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":4,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"ten_percent_owner":true}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":5,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"ten_percent_owner":true}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":6,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":7,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"ten_percent_owner":true}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":8,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-10-07T19:39:20.000Z","date":"2019-10-07","kind":"exercise","acquired":true,"shares":1993658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering.  The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the \"Versant Funds\") and Versant Venture Capital V (Canada) LP (\"Versant Canada\"). Versant Ventures V, LLC (\"Ventures V\") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Samuel D. Colella (\"Colella\"), William J. Link (\"Link\"), Bradley Bolzon, Ph.D (\"Bolzon\"), Kirk G. Nielsen (\"Nielsen\"), Thomas Woiwode (\"Woiwode\"), Jerel C. Davis (\"Davis\") and Robin L. Praeger (\"Praeger\") are managing directors of Ventures V.  Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa (\"Ozawa\") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein."}],"balance_after":2006328,"source":{"system":"sec-edgar","filing":"0001140361-19-018090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000114036119018090/form4.xml","form_type":"4"}}]}